[1. Bauer M. et al.: Lithium augmentation therapy in refractory depression: clinical evidence and neurobiological mechanisms. Can. J .Psychiatry, 48(7), 440, 2003.10.1177/070674370304800703]Search in Google Scholar
[2. Berggren U.: Effects of short-term lithium administration on tryptophan levels and 5- hydroxytryptamine synthesis in whole brain and brain regions in rats. J. Neural. Transm., 69, 115, 1987.10.1007/BF01244102]Search in Google Scholar
[3. Blier P., deMontigny C.: Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS. Eur. J. Pharmacol., 113, 69, 1985.]Search in Google Scholar
[4. Darmani N.A.: Cannabinoids of diverse structure inhibit two DOIinduced 5-HT(2A) receptor-mediated behaviors in mice. Pharmacol. Bioch. Beh., 68(2), 311, 2001.10.1016/S0091-3057(00)00477-9]Search in Google Scholar
[5. Fletcher P.J., Korth K.M., Chambers J.W.: Selective destruction of brain serotonin neurons by 5,7-dihydroxytryptamine increases responding for a conditioned reward. Psychopharmacol., 147, 291, 1999.]Search in Google Scholar
[6. Granoff M.I., Ashby C.R.: The effect of the repeated administration of the compound 3,4-metylenedioxymethamphetamine on the response of rats to the 5-HT2A,C receptor agonist (+/-)-1-(2,5-dimethoxy-4- iodophenyl)-2-aminopropane (DOI). Neuropsychobiol., 37, 36, 1998.]Search in Google Scholar
[7. Heal D.J. et al.: The influence of central noradrenergic function on 5-HT2-mediated head-twitch response in mice: possible implications for the actions of antidepressant drugs. Psychopharmacol., 89, 414, 1986.10.1007/BF02412113]Search in Google Scholar
[8. Herrero E. et al.: Tryptophan transport into plasma membrane vesicles derived from rat brain synpatosomes. J. Neurochem., 40, 332, 1983.10.1111/j.1471-4159.1983.tb11287.x]Search in Google Scholar
[9. Hotta I., Yamawaki S.: Possible involvement of presynaptic 5-HT autoreceptors in effect of lithium on 5-HT release in hippocampus of rat. Neuropsychopharmacol., 27, 987, 1988.]Search in Google Scholar
[10. Kofman O., Patishi Y.: Interactions of lithium and drugs that effect signal transduction on behaviour in rats. Eur. Neuropsychopharmacol., 9, 385, 1999.]Search in Google Scholar
[11. Kuhn D.M., Wolf W.A., Youdim M.B.H.: 5-Hydroxytryptamine release in vivo from a cytoplasmic pool: studies on the 5-HT behavioural syndrome in reserpinized rats. Br. J. Pharmacol., 84, 121, 1985.]Search in Google Scholar
[12. Licht R.W.: Lithium: still a major option in the management of bipolar disorder. CNS Neuroscience Therpeutics, 18, 219, 2012.10.1111/j.1755-5949.2011.00260.x]Search in Google Scholar
[13. Matsumoto K. et al.: α2-adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppresion of head-twitch behavior in mice. Pharmacol. Bioch. Behav., 56, 417, 1997.10.1016/S0091-3057(96)00223-7]Search in Google Scholar
[14. McDonald L.M. et al.: Enhancement of latent inhibition by two 5-HT2A receptor antagonists only when given at both pre-exposure and conditioning. Psychopharmacol., 169(3-4), 321, 2003.10.1007/s00213-002-1173-4]Search in Google Scholar
[15. Munoz-Castaneda J.R. et al.: Role of serotonin in cerebral oxidative stress in rats. Acta Neurobiol. Exp., 66, 1, 2006.]Search in Google Scholar
[16. Swann A.C. et al.: Differential effects of short and long term lithium on tryptophan uptake and serotonergic function in cat brain. Life Sci., 28, 247, 1986.10.1016/0024-3205(81)90078-3]Search in Google Scholar
[17. Treiser S.L. et al.: Lithium increases serotonin release and decreases serotonin receptors in the hippocampus. Science, 213, 1529, 1981.10.1126/science.62691806269180]Search in Google Scholar
[18. Yamada K., Furukawa T.: Serotonergic function in mouse head twitches by lithium and reserpine. Psychopharmacol., 28, 61(3), 255, 1979. 10.1007/BF00432268109889]Search in Google Scholar